Name: Dr Donald Drakeman
Distinguished Research Professor, University of Notre Dame (US), and Fellow, Operations and Technology Management, Cambridge Judge Business School

Events this person is speaking at:

Monday 26 October 2020 (3rd Week, Michaelmas Term)

Why Were the Checkpoint Inhibitors Developed into Drugs?
Date: 26 October 2020, 12:00 - 13:00 (Monday, 3rd week, Michaelmas 2020)
Speaker : Dr Donald Drakeman (Distinguished Research Professor, University of Notre Dame (US), and Fellow, Operations and Technology Management, Cambridge Judge Business School)
Venue: Kennedy Institute of Rheumatology, Headington OX3 7FY
Venue Details: This seminar will be held using Zoom. Please register here: https://zoom.us/meeting/register/tJIkdO-rqzwsGtyGKaCW65anWJqcYkaCXzRC
Organisers: Jennifer Pope (Kennedy Institute of Rheumatology), Professor Irina Udalova (Kennedy Institute of Rheumatology)
Host: Professor Fiona Powrie (Kennedy Institute of Rheumatlogy)